A comparison of the effects and interactions of cromakalim and glibenclamide in cardiac and vascular tissues.
BoSmith
R E
RE
Bioscience II Department, ICI Pharmaceuticals, Macclesfield, Cheshire, Great Britain.
Briggs
I
I
Grant
T L
TL
Grimwood
S
S
Russell
N J
NJ
Stone
M A
MA
Wickenden
A D
AD
D000818:Animals; D001011:Aorta / Q000187:drug effects; D001578:Benzopyrans / Q000494:pharmacology*; D019806:Cromakalim; D004594:Electrophysiology; D005905:Glyburide / Q000494:pharmacology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D010210:Papillary Muscles / Q000187:drug effects*; D011169:Portal Vein / Q000187:drug effects; D015221:Potassium Channels / Q000187:drug effects*; D011758:Pyrroles / Q000494:pharmacology*; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology*
D001578:Benzopyrans; D015221:Potassium Channels; D011758:Pyrroles; D014665:Vasodilator Agents; D019806:Cromakalim; D005905:Glyburide